文献速递银屑病与炎症性皮肤病

皮肤源糖皮质激素合成功能障碍是银屑病致病机制

Dysfunctional Skin-Derived Glucocorticoid Synthesis Is a Pathogenic Mechanism of Psoriasis.
PubMed 文献 · J Invest Dermatol · 2017-03-28

该研究探讨银屑病皮肤局部糖皮质激素(GC)合成与GC受体表达是否异常,并利用表皮GC受体敲除小鼠结合肾上腺切除区分局部与全身GC作用。结果显示,非皮损与皮损银屑病皮肤中GC从头合成及GC受体表达均功能障碍;角质形成细胞来源GC合成可保护皮肤免受炎症攻击。

要点

  • 银屑病非皮损与皮损皮肤均存在GC合成及GC受体表达功能障碍
  • 角质形成细胞来源GC合成对控制局部皮肤炎症至关重要
  • 银屑病皮肤GC通路缺失是该复杂炎症性疾病的附加病理过程

核心结论

  • 皮肤局部从头GC合成对控制炎症至关重要,银屑病皮肤中GC通路缺失是该病的附加病理过程。

研究设计与样本

  • 研究检测银屑病非皮损与皮损皮肤中GC从头合成及GC受体表达,并使用表皮GC受体敲除小鼠结合肾上腺切除区分局部与全身GC活性。

主要发现

  • 银屑病非皮损和皮损皮肤中GC从头合成与GC受体表达均功能障碍。
  • 成年表皮GC受体敲除小鼠的代偿表现表明,角质形成细胞来源GC合成可保护皮肤免受佛波醇12-肉豆蔻酸酯13-乙酸酯局部诱导的炎症攻击。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Glucocorticoids (GC) are the primary steroids that regulate inflammation and have been exploited therapeutically in inflammatory skin diseases. Despite the broad-spectrum therapeutic use of GC, the biochemical rationale for locally treating inflammatory skin conditions is poorly understood, as systemic GC production remains largely functional in these patients. GC synthesis has been well characterized in healthy skin, but the pathological consequence has not been examined. Here we show de novo GC synthesis, and GC receptor expression is dysfunctional in both nonlesional and lesional psoriatic skin. Use of GC receptor epidermal knockout mice with adrenalectomy allowed for the distinction between local (keratinocyte) and systemic GC activity. Compensation exhibited by adult GC receptor epidermal knockout mice demonstrated that keratinocyte-derived GC synthesis protected skin from topical phorbol 12-myristate 13-acetate-induced inflammatory assault. Thus, localized de novo GC synthesis in skin is essential for controlling inflammation, and loss of the GC pathway in psoriatic skin represents an additional pathological process in this complex inflammatory skin disease.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Hannen R, Udeh-Momoh C, Upton J, et al. Dysfunctional Skin-Derived Glucocorticoid Synthesis Is a Pathogenic Mechanism of Psoriasis. J Invest Dermatol. 2017. PMID: 28359725. doi:10.1016/j.jid.2017.02.984

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。